Literature DB >> 3747693

Cholesteatoma staging.

W L Meyerhoff, J Truelson.   

Abstract

Manuscripts reporting results of surgery for chronic otitis media would be more meaningful if standardized nomenclature were used in describing the type of surgery performed and if standardized classifications were used for the disease process. Standardized nomenclature for surgery type and classifications for chronic otitis media exists. A Classification for cholesteatoma, based on pathophysiology, location, eustachian tube function, ossicular defects, and presence or absence of complications is proposed. Congenital cholesteatoma is that which has its nidus of trapped squamous epithelium present at birth. Primary acquired cholesteatoma is associated with a defect in the pars flaccida, while secondary acquired cholesteatoma is associated with a defect in the pars tensa. Tertiary acquired cholesteatoma is defined as that which occurs behind a normal appearing tympanic membrane as the result of implantation or an antecedent middle ear inflammation.

Entities:  

Mesh:

Year:  1986        PMID: 3747693

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Congenital cholesteatoma with spontaneous epidural abscess, sinus thrombosis and cutaneous fistula.

Authors:  A Gök; M Kanlikama; C Ozsaraç
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

2.  Cerebellopontine angle epidermoid cysts: a report on 30 cases.

Authors:  C E deSouza; R deSouza; S da Costa; N Sperling; T H Yoon; M M Abdelhamid; R R Sharma; A Goel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

3.  Cholesteatoma Classification: Review of Literature and Proposed Indian Classification System-TAMPFIC.

Authors:  M B Bharathi; Pranshu Mehta; Kavya Sivapuram; D Sandhya
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-09-29

Review 4.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

5.  Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma.

Authors:  Shunsuke Miyake; Toru Miwa; Go Yoneda; Ayumi Kanemaru; Haruki Saito; Ryosei Minoda; Yorihisa Orita; Hideyuki Saito; Hirofumi Jono
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

6.  Assessing the Prognostic Value of the ChOLE Classification in Predicting the Severity of Acquired Cholesteatoma.

Authors:  Maura C Eggink; Maarten J F de Wolf; Fenna A Ebbens; Frederik G Dikkers; Erik van Spronsen
Journal:  Otol Neurotol       Date:  2022-04-01       Impact factor: 2.311

7.  Association of CARD8 Activating Polymorphism With Bone Erosion in Cholesteatoma Patients.

Authors:  Neel Sangal; John Yan; Jessica Pryor; Marcus L Elias; Biju Joseph; Luis Ulloa; Robert W Jyung
Journal:  Laryngoscope       Date:  2020-05-12       Impact factor: 2.970

Review 8.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.